|
1
|
Dai WJ and Jiang HC: Advances in gene
therapy of liver cirrhosis: a review. World J Gastroenterol. 7:1–8.
2001.PubMed/NCBI
|
|
2
|
Mormone E, George J and Nieto N: Molecular
pathogenesis of hepatic fibrosis and current therapeutic
approaches. Chem Biol Interact. 193:225–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pinzani M and Rombouts K: Liver fibrosis:
from the bench to clinical targets. Dig Liver Dis. 36:231–242.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ochi T, Kawakita T and Nomoto K: Effects
of Hochu-ekki-to and Ninjin-youei-to, traditional Japanese
medicines, on porcine serum-induced liver fibrosis in rats.
Immunopharmacol Immunotoxicol. 26:285–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shiga A, Shirota K, Ikeda T and Nomura Y:
Morphological and immunohistochemical studies on porcine
serum-induced rat liver fibrosis. J Vet Med Sci. 59:159–167. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baba Y and Doi K: MHC class II-related
genes expression in porcine-serum-induced rat hepatic fibrosis. Exp
Mol Pathol. 77:214–221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seki E, Brenner DA and Karin M: A liver
full of JNK: signaling in regulation of cell function and disease
pathogenesis, and clinical approaches. Gastroenterology.
143:307–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Canbay A, Friedman S and Gores GJ:
Apoptosis: the nexus of liver injury and fibrosis. Hepatology.
39:273–278. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Domitrović R and Jakovac H: Effects of
standardized bilberry fruit extract (Mirtoselect®) on
resolution of CCl4-induced liver fibrosis in mice. Food Chem
Toxicol. 49:848–854. 2011.PubMed/NCBI
|
|
10
|
Friedman SL: Stellate cells: a moving
target in hepatic fibrogenesis. Hepatology. 40:1041–1043. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang BE: Treatment of chronic liver
diseases with traditional Chinese medicine. J Gastroenterol
Hepatol. 15(Suppl): E67–E70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z, Li P, Zhao D, Tang H and Guo J:
Protective effect of extract of Cordyceps sinensis in middle
cerebral artery occlusion-induced focal cerebral ischemia in rats.
Behav Brain Funct. 6:612010.PubMed/NCBI
|
|
13
|
Li J, Tian XP, Zhu TJ, Yang LL and Li WJ:
Streptomyces fildesensis sp nov, a novel streptomycete
isolated from Antarctic soil. Antonie Van Leeuwenhoek. 100:537–543.
2011. View Article : Google Scholar
|
|
14
|
Wu CS, Piao XX, Piao DM, Jin YR and Li CH:
Treatment of pig serum-induced rat liver fibrosis with
Boschniakia rossica, oxymatrine and interferon-alpha. World
J Gastroenterol. 11:122–126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andrade RG, Gotardo BM, Assis BC, Mengel J
and Andrade ZA: Immunological tolerance to pig-serum partially
inhibits the formation of septal fibrosis of the liver in
Capillaria hepatica-infected rats. Mem Inst Oswaldo Cruz.
99:703–707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jamall IS, Finelli VN and Que Hee SS: A
simple method to determine nanogram levels of 4-hydroxyproline in
biological tissues. Anal Biochem. 112:70–75. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY,
Shyu JC, Hsieh YS, Tsai CC and Liu YC: Effects of silymarin on the
resolution of liver fibrosis induced by carbon tetrachloride in
rats. J Viral Hepat. 15:508–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawai K, Uetsuka K, Doi K and Nakayama H:
The activity of matrix metalloproteinases (MMPS) and tissue
inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs
and rats. J Vet Med Sci. 68:105–111. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamada G: Histopathological
characteristics and clinical significance of New Inuyama
Classification in chronic hepatitis B. Nihon Rinsho.
62(Suppl)8:290–292. 2004.(In Japanese).
|
|
20
|
Popper H and Uenfriend S: Hepatic
fibrosis. Correlation of biochemical and morphologic
investigations. Am J Med. 49:707–721. 1970.PubMed/NCBI
|
|
21
|
Toda K, Kumagai N, Kaneko F, Tsunematsu S,
Tsuchimoto K, Saito H and Hibi T: Pentoxifylline prevents pig
serum-induced rat liver fibrosis by inhibiting interleukin-6
production. J Gastroenterol Hepatol. 24:860–865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu YC, Chiu YT, Lee CY, Lin YL and Huang
YT: Increases in fibrosis-related gene transcripts in livers of
dimethylnitrosamine-intoxicated rats. J Biomed Sci. 11:408–417.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polavarapu R, Spitz DR, Sim JE, Follansbee
MH, Oberley LW, Rahemtulla A and Nanji AA: Increased lipid
peroxidation and impaired antioxidant enzyme function is associated
with pathological liver injury in experimental alcoholic liver
disease in rats fed diets high in corn oil and fish oil.
Hepatology. 27:1317–1323. 1998. View Article : Google Scholar
|
|
24
|
Dang SS, Wang BF, Cheng YA, Song P, Liu ZG
and Li ZF: Inhibitory effects of saikosaponin-d on CCl4-induced
hepatic fibrogenesis in rats. World J Gastroenterol. 13:557–563.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kaneda H, Hashimoto E, Yatsuji S,
Tokushige K and Shiratori K: Hyaluronic acid levels can predict
severe fibrosis and platelet counts can predict cirrhosis in
patients with nonalcoholic fatty liver disease. J Gastroenterol
Hepatol. 21:1459–1465. 2006.
|
|
26
|
Choi JH, Hwang YP, Choi CY, Chung YC and
Jeong HG: Anti-fibrotic effects of the anthocyanins isolated from
the purple-fleshed sweet potato on hepatic fibrosis induced by
dimethylnitrosamine administration in rats. Food Chem Toxicol.
48:3137–3143. 2010. View Article : Google Scholar
|
|
27
|
Otogawa K, Ogawa T, Shiga R, Ikeda K and
Kawada N: Induction of tropomyosin during hepatic stellate cell
activation and the progression of liver fibrosis. Hepatol Int.
3:378–383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carpino G, Morini S, Ginanni Corradini S,
et al: Alpha-SMA expression in hepatic stellate cells and
quantitative analysis of hepatic fibrosis in cirrhosis and in
recurrent chronic hepatitis after liver transplantation. Dig Liver
Dis. 37:349–356. 2005. View Article : Google Scholar
|
|
29
|
Gressner AM and Weiskirchen R: Modern
pathogenetic concepts of liver fibrosis suggest stellate cells and
TGF-beta as major players and therapeutic targets. J Cell Mol Med.
10:76–99. 2006. View Article : Google Scholar
|
|
30
|
Tsukada S, Westwick JK, Ikejima K, Sato N
and Rippe RA: SMAD and p38 MAPK signaling pathways independently
regulate alpha1(I) collagen gene expression in unstimulated and
transforming growth factor-beta-stimulated hepatic stellate cells.
J Biol Chem. 280:10055–10064. 2005. View Article : Google Scholar
|
|
31
|
Inagaki Y and Okazaki I: Emerging insights
into Transforming growth factor beta Smad signal in hepatic
fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Genes Dev. 19:2783–2810. 2005.PubMed/NCBI
|
|
33
|
Kopp J, Preis E, Said H, Hafemann B,
Wickert L, Gressner AM, Pallua N and Dooley S: Abrogation of
transforming growth factor-beta signaling by SMAD7 inhibits
collagen gel contraction of human dermal fibroblasts. J Biol Chem.
280:21570–21576. 2005. View Article : Google Scholar : PubMed/NCBI
|
